BMO Capital raised the firm’s price target on Thomson Reuters to $165 from $155 and keeps an Outperform rating on the shares. The company’s Q4 results were decent with in-line revenue and solid EBITDA that beat expectations by 3%, reflecting a GenAI news transaction, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on TRI: